Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giulia Pasello

Showing results (91-100 of 167) with videos related to

Pageof 17
Sort By:
Cancers|August 12, 2022
Sarcopenia as a Predictor of Short- and Long-Term Outcomes in Patients Surgically Treated for Malignant Pleural MesotheliomaEleonora Faccioli, Stefano Terzi, Chiara Giraudo, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|November 28, 2024
Surgery for pleural mesothelioma in multimodality setting: comparison between surgical techniques in a high-volume centreEleonora Faccioli, Andrea Dell'Amore, Giulia Lorenzoni, et al.
Cancers|February 26, 2025
NON-SMALL-CELL LUNG CANCER: Real-World Population-Based Cohorts' StudyAlessandra Buja, Massimo Rugge, Alberto Bortolami, et al.
The Oncologist|May 31, 2022
Tumor Immune-Infiltrate Landscape After Chemo-Radiotherapy in a Case Series of Patients with Non-small Cell Lung Cancer: Pretreatment Predictors and Correlation With OutcomeAlberto Pavan, Alessandra Ferro, Francesco Fortarezza, et al.
International Journal of Molecular Sciences|March 14, 2026
<i>HER2</i> Alterations in Non-Small Cell Lung Cancer: Emerging Perspectives on the Therapeutic LandscapePaola Muscolino, Elena Fassi, Diego Signorelli, et al.
Journal for Immunotherapy of Cancer|July 2, 2024
Extensive-stage small-cell lung cancer in patients receiving atezolizumab plus carboplatin-etoposide: stratification of outcome based on a composite score that combines gene expression profiling and immune characterization of microenvironmentAnna Tosi, Martina Lorenzi, Paola Del Bianco, et al.
Critical Reviews in Oncology/Hematology|August 17, 2025
Clinical insight on the pathway of SLFN11 as emergent biomarker in SCLCDaniela Scattolin, Frank W J Heijboer, Jules L Derks, et al.
Frontiers in Oncology|January 5, 2026
Radiomic approach to support multidisciplinary tumor board decision-making in locally advanced non-small cell lung cancerGiulia Pasello, Harel Kotler, Alessandra Ferro, et al.
Frontiers in Oncology|April 30, 2024
Pathological complete response in a patient with pleural mesothelioma treated with immunotherapy: a case reportEleonora Faccioli, Federica Grosso, Andrea Dell'Amore, et al.
Frontiers in Immunology|February 7, 2024
Real-world impact of the introduction of chemo-immunotherapy in extended small cell lung cancer: a multicentric analysisLaura Bonanno, Lorenzo Calvetti, Alessandro Dal Maso, et al.
Pageof 17

Showing results (91-100 of 167) with videos related to

Sort By:
Pageof 17
Cancers|August 12, 2022
Sarcopenia as a Predictor of Short- and Long-Term Outcomes in Patients Surgically Treated for Malignant Pleural MesotheliomaEleonora Faccioli, Stefano Terzi, Chiara Giraudo, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|November 28, 2024
Surgery for pleural mesothelioma in multimodality setting: comparison between surgical techniques in a high-volume centreEleonora Faccioli, Andrea Dell'Amore, Giulia Lorenzoni, et al.
Cancers|February 26, 2025
NON-SMALL-CELL LUNG CANCER: Real-World Population-Based Cohorts' StudyAlessandra Buja, Massimo Rugge, Alberto Bortolami, et al.
The Oncologist|May 31, 2022
Tumor Immune-Infiltrate Landscape After Chemo-Radiotherapy in a Case Series of Patients with Non-small Cell Lung Cancer: Pretreatment Predictors and Correlation With OutcomeAlberto Pavan, Alessandra Ferro, Francesco Fortarezza, et al.
International Journal of Molecular Sciences|March 14, 2026
<i>HER2</i> Alterations in Non-Small Cell Lung Cancer: Emerging Perspectives on the Therapeutic LandscapePaola Muscolino, Elena Fassi, Diego Signorelli, et al.
Journal for Immunotherapy of Cancer|July 2, 2024
Extensive-stage small-cell lung cancer in patients receiving atezolizumab plus carboplatin-etoposide: stratification of outcome based on a composite score that combines gene expression profiling and immune characterization of microenvironmentAnna Tosi, Martina Lorenzi, Paola Del Bianco, et al.
Critical Reviews in Oncology/Hematology|August 17, 2025
Clinical insight on the pathway of SLFN11 as emergent biomarker in SCLCDaniela Scattolin, Frank W J Heijboer, Jules L Derks, et al.
Frontiers in Oncology|January 5, 2026
Radiomic approach to support multidisciplinary tumor board decision-making in locally advanced non-small cell lung cancerGiulia Pasello, Harel Kotler, Alessandra Ferro, et al.
Frontiers in Oncology|April 30, 2024
Pathological complete response in a patient with pleural mesothelioma treated with immunotherapy: a case reportEleonora Faccioli, Federica Grosso, Andrea Dell'Amore, et al.
Frontiers in Immunology|February 7, 2024
Real-world impact of the introduction of chemo-immunotherapy in extended small cell lung cancer: a multicentric analysisLaura Bonanno, Lorenzo Calvetti, Alessandro Dal Maso, et al.
Pageof 17